Literature DB >> 21084513

Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center.

Kyle Petersen1, Suzanne C Cannegieter, Tanny J van der Reijden, Beppie van Strijen, David M You, Britta S Babel, Andrew I Philip, Lenie Dijkshoorn.   

Abstract

The epidemiology of Acinetobacter baumannii emerging in combat casualties is poorly understood. We analyzed 65 (54 nonreplicate) Acinetobacter isolates from 48 patients (46 hospitalized and 2 outpatient trainees entering the military) from October 2004 to October 2005 for genotypic similarities, time-space relatedness, and antibiotic susceptibility. Clinical and surveillance cultures were compared by amplified fragment length polymorphism (AFLP) genomic fingerprinting to each other and to strains of a reference database. Antibiotic susceptibility was determined, and multiplex PCR was performed for OXA-23-like, -24-like, -51-like, and -58-like carbapenemases. Records were reviewed for overlapping hospital stays of the most frequent genotypes, and risk ratios were calculated for any association of genotype with severity of Acute Physiology and Chronic Health Evaluation II (APACHE II) score or injury severity score (ISS) and previous antibiotic use. Nineteen genotypes were identified; two predominated, one consistent with an emerging novel international clone and the other unique to our database. Both predominant genotypes were carbapenem resistant, were present at another hospital before patients' admission to our facility, and were associated with higher APACHE II scores, higher ISSs, and previous carbapenem antibiotics in comparison with other genotypes. One predominated in wound and respiratory isolates, and the other predominated in wound and skin surveillance samples. Several other genotypes were identified as European clones I to III. Acinetobacter genotypes from recruits upon entry to the military, unlike those in hospitalized patients, did not include carbapenem-resistant genotypes. Acinetobacter species isolated from battlefield casualties are diverse, including genotypes belonging to European clones I to III. Two carbapenem-resistant genotypes were epidemic, one of which appeared to belong to a novel international clone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084513      PMCID: PMC3020478          DOI: 10.1128/JCM.00766-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Inflammatory biomarkers in combat wound healing.

Authors:  Jason S Hawksworth; Alexander Stojadinovic; Frederick A Gage; Doug K Tadaki; Philip W Perdue; Jonathan Forsberg; Thomas A Davis; James R Dunne; John W Denobile; Trevor S Brown; Eric A Elster
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

2.  Association of bacterial colonization at the time of presentation to a combat support hospital in a combat zone with subsequent 30-day colonization or infection.

Authors:  Robert L Kaspar; Matthew E Griffith; Paul B Mann; Devon J Lehman; Nicholas G Conger; Duane R Hospenthal; Clinton K Murray
Journal:  Mil Med       Date:  2009-09       Impact factor: 1.437

3.  Perioperative blood transfusion in combat casualties: a pilot study.

Authors:  James R Dunne; Jason S Hawksworth; Alexander Stojadinovic; Fred Gage; Doug K Tadaki; Philip W Perdue; Jonathan Forsberg; Tom Davis; John W Denobile; Trevor S Brown; Eric A Elster
Journal:  J Trauma       Date:  2009-04

Review 4.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 5.  Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control.

Authors:  I Uçkay; H Sax; S Harbarth; L Bernard; D Pittet
Journal:  J Hosp Infect       Date:  2008-01       Impact factor: 3.926

Review 6.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

7.  Can Escherichia coli be used as an indicator organism for transmission events in hospitals?

Authors:  P J van den Broek; A T Bernards; T J K van der Reijden; B van Strijen; L Dijkshoorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-06       Impact factor: 3.267

8.  Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.

Authors:  Alexandr Nemec; Lenka Krízová; Martina Maixnerová; Laure Diancourt; Tanny J K van der Reijden; Sylvain Brisse; Peterhans van den Broek; Lenie Dijkshoorn
Journal:  J Antimicrob Chemother       Date:  2008-05-13       Impact factor: 5.790

9.  Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker.

Authors:  Timothy J Whitman; Sonia S Qasba; Joseph G Timpone; Britta S Babel; Matthew R Kasper; Judith F English; John W Sanders; Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Mark W Eshoo; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.

Authors:  David M Livermore; Robert L R Hill; Hazel Thomson; André Charlett; Jane F Turton; Rachel Pike; Bharat C Patel; Rohini Manuel; Stephen Gillespie; Indran Balakrishnan; Stephen P Barrett; Nigel Cumberland; Mary Twagira
Journal:  Int J Antimicrob Agents       Date:  2009-11-11       Impact factor: 5.283

View more
  12 in total

1.  Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis.

Authors:  Daniel V Zurawski; Mitchell G Thompson; Christin N McQueary; Malcolm N Matalka; Jason W Sahl; David W Craft; David A Rasko
Journal:  J Bacteriol       Date:  2012-03       Impact factor: 3.490

2.  Phenotypic and genotypic changes over time and across facilities of serial colonizing and infecting Escherichia coli isolates recovered from injured service members.

Authors:  Katrin Mende; Miriam L Beckius; Wendy C Zera; Xin Yu; Kristelle A Cheatle; Deepak Aggarwal; Ping Li; Bradley A Lloyd; David R Tribble; Amy C Weintrob; Clinton K Murray
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

3.  Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities.

Authors:  Chris Rowe Taitt; Tomasz A Leski; Michael G Stockelman; David W Craft; Daniel V Zurawski; Benjamin C Kirkup; Gary J Vora
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

4.  Longitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methods.

Authors:  Brooke K Decker; Federico Perez; Andrea M Hujer; Kristine M Hujer; Geraldine S Hall; Michael R Jacobs; Wondwossen A Gebreyes; Scott T Zoll; Christian Massire; Mark W Eshoo; David J Ecker; Philip N Rather; Robert A Bonomo
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

Review 5.  Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens.

Authors:  Kyungwon Lee; Dongeun Yong; Seok Hoon Jeong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

6.  Characterization of a novel international clonal complex (CC32) of Acinetobacter baumannii with epidemic potential.

Authors:  G J Da Silva; T Van Der Reijden; S Domingues; N Mendonça; K Petersen; L Dijkshoorn
Journal:  Epidemiol Infect       Date:  2013-09-30       Impact factor: 4.434

7.  Clinico-epidemiological nature and antibiotic susceptibility profile of Acinetobacter species.

Authors:  Shirin Biglari; Alfizah Hanafiah; Ramliza Ramli; Md Mostafizur Rahman; Tzar Mohd Nizam Khaithir
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

8.  Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis.

Authors:  Yolande Hauck; Charles Soler; Patrick Jault; Audrey Mérens; Patrick Gérome; Christine Mac Nab; François Trueba; Laurent Bargues; Hoang Vu Thien; Gilles Vergnaud; Christine Pourcel
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

9.  Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.

Authors:  Daniel De Vos; Jean-Paul Pirnay; Florence Bilocq; Serge Jennes; Gilbert Verbeken; Thomas Rose; Elkana Keersebilck; Petra Bosmans; Thierry Pieters; Mony Hing; Walter Heuninckx; Frank De Pauw; Patrick Soentjens; Maia Merabishvili; Pieter Deschaght; Mario Vaneechoutte; Pierre Bogaerts; Youri Glupczynski; Bruno Pot; Tanny J van der Reijden; Lenie Dijkshoorn
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

10.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Complex Isolates from Patients that were Injured During the Eastern Ukrainian Conflict.

Authors:  Heike Granzer; Ralf Matthias Hagen; Philipp Warnke; Wolfgang Bock; Tobias Baumann; Norbert Georg Schwarz; Andreas Podbielski; Hagen Frickmann; Thomas Koeller
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.